Idorsia Ltd (OTCMKTS:IDRSF – Get Free Report) traded up 63% on Thursday . The company traded as high as $1.50 and last traded at $1.50. 39,500 shares were traded during trading, an increase of 1,094% from the average session volume of 3,307 shares. The stock had previously closed at $0.92.
Idorsia Stock Performance
The stock has a 50 day simple moving average of $1.46 and a two-hundred day simple moving average of $2.11.
Idorsia Company Profile
Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.
Read More
- Five stocks we like better than Idorsia
- Manufacturing Stocks Investing
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- 3 Small Caps With Big Return Potential
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- Golden Cross Stocks: Pattern, Examples and Charts
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Idorsia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Idorsia and related companies with MarketBeat.com's FREE daily email newsletter.
